1.70
price down icon2.86%   -0.05
after-market 시간 외 거래: 1.78 0.08 +4.71%
loading
전일 마감가:
$1.75
열려 있는:
$1.71
하루 거래량:
28,496
Relative Volume:
0.25
시가총액:
$66.15M
수익:
$134.00K
순이익/손실:
$-9.93M
주가수익비율:
-5.00
EPS:
-0.34
순현금흐름:
$-6.72M
1주 성능:
-12.82%
1개월 성능:
-8.11%
6개월 성능:
-10.53%
1년 성능:
+1.80%
1일 변동 폭
Value
$1.65
$1.73
1주일 범위
Value
$1.65
$1.9587
52주 변동 폭
Value
$1.41
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
명칭
Entera Bio Ltd
Name
전화
972-2-532-7151
Name
주소
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
ENTX's Discussions on Twitter

ENTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ENTX
Entera Bio Ltd
1.70 66.15M 134.00K -9.93M -6.72M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-03-22 개시 Aegis Capital Buy

Entera Bio Ltd 주식(ENTX)의 최신 뉴스

pulisher
Mar 29, 2025

Entera Bio Reports Transformative Year in 2024 - TipRanks

Mar 29, 2025
pulisher
Mar 28, 2025

Entera Bio Ltd. (ENTX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio Announces 2024 Financial Results and Updates - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio's Breakthrough: Oral Peptide Programs Show Promise as 2024 Results Reveal $21M War Chest - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Mar 28, 2025
pulisher
Mar 21, 2025

Entera Bio Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

Entera Bio’s (ENTX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Opko Health, Entera Bio sign agreement for oral GLP-1/glucagon dual agonist peptide - BioWorld MedTech

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO and Entera team up on oral obesity candidate - The Pharma Letter

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO and Entera Bio partner on oral obesity treatment By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO And Entera Bio Team Up For Game-Changing Obesity Pill - Finimize

Mar 18, 2025
pulisher
Mar 17, 2025

OPKO and Entera partner to develop obesity pill -March 17, 2025 at 08:54 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Entera Bio Collaborates with OPKO for Oral GLP-1/Glucagon - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO, Entera to Co-Develop Oral GLP-1/Glucagon Therapy for Obesity -March 17, 2025 at 08:38 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO and Entera Bio partner on oral obesity treatment - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO Health and Entera Bio Enter into Collaboration - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera Join Forces to Challenge Injectable Market - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera Bio Join Forces for Game-Changing Pill - Stock Titan

Mar 17, 2025
pulisher
Mar 07, 2025

Entera Bio (ENTX) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Feb 28, 2025

Entera Bio Ltd. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 24, 2025

Entera Bio to Participate in Upcoming Events - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can Entera Bio's Upcoming Scientific Data Reshape Oral Peptide Therapy? Major Conference Schedule Revealed - Stock Titan

Feb 24, 2025
pulisher
Feb 19, 2025

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskel - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Could This Oral Osteoporosis Treatment Replace Daily Injections? Phase 2 Data Reveals Promising Results - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 31.6% in January - MarketBeat

Feb 17, 2025
pulisher
Feb 07, 2025

US Penny Stocks: 3 Picks With Market Caps Over $60M - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Feb 06, 2025
pulisher
Feb 04, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

145,843 Shares in Entera Bio Ltd. (NASDAQ:ENTX) Acquired by Perigon Wealth Management LLC - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 23.1% in January - MarketBeat

Feb 03, 2025
pulisher
Jan 27, 2025

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Jan 27, 2025
pulisher
Jan 27, 2025

Entera Bio CEO to Present Business Updates at Oppenheimer Healthcare Conference - StockTitan

Jan 27, 2025
pulisher
Jan 18, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Decrease in Short Interest - Defense World

Jan 18, 2025
pulisher
Jan 10, 2025

Entera Bio files Exhibit 5.1 with SEC By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Jan 10, 2025

Entera Bio files Exhibit 5.1 with SEC - Investing.com

Jan 10, 2025
pulisher
Jan 07, 2025

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.1% – Still a Buy? - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Entera Bio (NASDAQ:ENTX) Shares Up 1.1%Time to Buy? - MarketBeat

Jan 07, 2025
pulisher
Dec 24, 2024

Hypoparathyroidism Market Overview, Trends, Insights, - openPR

Dec 24, 2024
pulisher
Dec 07, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Simply Wall St

Dec 07, 2024
pulisher
Dec 01, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Rises By 19.0% - MarketBeat

Dec 01, 2024
pulisher
Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024
pulisher
Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024

Entera Bio Ltd (ENTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):